Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Fitstry vs Healthicare

Fitstry
Graded #300

Lower grade

vs+4.299999999999997
Healthicare
Graded #221

Higher grade

The verdict

Healthicare takes it — 65.5/100 to 61.2/100.

Healthicare grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Healthicare is a GLP-1 telehealth platform offering both compounded options and a full brand-name menu — Ozempic, Wegovy, Mounjaro, and Zepbound — on a single account.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHealthicare +29
29
58
Dose & formulationHealthicare +13
75
88
Clinical oversightFitstry +10
81
71
Labs & monitoringFitstry +20
73
53
FulfillmentFitstry +5
67
62
Contract termsEven
47
47
Fitstry · left barHealthicare · right bar

The numbers

MetricFitstryHealthicare
WeighScore61.2/10065.5/100
GradeCC
Scorecard rank#300#221
Semaglutide$179/mo (annual plan, plus a separate fee, compounded)$174/mo (compounded)
Tirzepatide$269/mo (annual plan, compounded)$264/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualYesYes
Fitstry

Graded #300 · C

Strengths

  • Transparent pricing before you commit — compounded semaglutide from $179/mo, tirzepatide from $269/mo, oral GLP-1 from $209/mo (annual plan)
  • Free screening with a one-time $99 program fee that is fully refunded if a clinician can't prescribe ('Approved, or Your $99 Back')
  • Monthly price bundles a lab panel (CMP, A1c, lipids, TSH), unlimited clinician access, bi-weekly care coaching and a 24/7 Care Line
  • Runs under Weightstry, LLC, a LegitScript-certified practice with an independently verifiable seal, a named support email and phone
  • Full compounded lineup — weekly injection, daily oral tablet and microdosing options

Where it loses points

  • Month-to-month pricing is notably higher than the annual plan ($249 vs $179 semaglutide, $339 vs $269 tirzepatide)
  • Compounded semaglutide and tirzepatide only — no brand-name (Wegovy/Zepbound) options
  • Framed for women 40+, and serves 49 states rather than all 50 (the excluded state isn't disclosed publicly)
  • Works with state-licensed compounding pharmacies but doesn't name a specific pharmacy partner on the Fitstry page
  • Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name
Healthicare

Graded #221 · C

Strengths

  • Both compounded and full brand-name menu (Ozempic, Wegovy, Mounjaro, Zepbound) on one platform
  • Pharmacy partner named publicly: Jungle Jim's Pharmacy (F&F Pharmacies Inc.), Fairfield, OH
  • Clinical lead named publicly: Dr. Jonah Mink, Beluga Health
  • Compounded semaglutide from $147.90/mo on the 3-month plan ($174/mo billed monthly) — lower end of the segment

Where it loses points

  • Not available in several states including CA, NV, NJ, NC, TX, MA — verify your state first
  • Brand-name first-month pricing of $1,199.99–$1,299.99 is at or above cash retail; value is on the compounded tier
  • Footer references 'Sunshine Health Studios Inc.' — relationship to the domain owner is unclear

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard